GS71 vs GSK: Side-by-Side Comparison
Compare GSK plc (GS71) and GSK Plc (GSK) side by side: market cap EUR 91.51B vs USD 107.63B, P/E 13.8 vs 14.0. Financials, growth and model signals on Bullrun.
| Metric | GS71 | GSK |
|---|---|---|
| Company | GSK plc | GSK Plc |
| Country / Exchange | United Kingdom · XETRA | United Kingdom · NYSE |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers-General |
| Market cap | EUR 91.51B | USD 107.63B |
| P/E ratio | 13.8 | 14.0 |
| Dividend yield | 3.40% | 3.34% |
| Valuation model | 30.7% undervalued | 36.9% undervalued |
| Revenue (latest FY) | GBP 32.67B | — |
| Revenue growth YoY | +4.1% | — |
| Net income | GBP 6.29B | — |
| Gross margin | 72.4% | — |
| Diluted EPS | 1.39 | — |